BMJ Best Practice

参考文献

关键文献

Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015. http://www.topalbertadoctors.org (last accessed 22 October 2016).

参考文章

1.  Denny FW, Murphy TF, Clyde WA Jr, et al. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983;71:871-876.

2.  Tong MC, Chu MC, Leighton SE, et al. Adult croup. Chest. 1996;109:1659-1662.

3.  Marx A, Torok TJ, Holman RC, et al. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis. 1997;176:1423-1427.

4.  Chapman RS, Henderson FW, Clyde WA Jr, et al. The epidemiology of tracheobronchitis in pediatric practice. Am J Epidemiol. 1981;114:786-797.

5.  Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-450.

6.  Van der Hoek L, Sure K, Ihorst G, et al. Human coronavirus NL63 infection is associated with croup. Adv Exp Med Biol. 2006;581:485-491.

7.  D'Souza RM, D'Souza R. Vitamin A for preventing secondary infections in children with measles - a systematic review. J Trop Pediatr. 2002;48:72-77.

8.  Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990 Jul 19;323(3):160-4.

9.  Havaldar PV. Dexamethasone in laryngeal diphtheritic croup. Ann Trop Paediatr. 1997;17:21-23.

10.  Kapustian VA, Boldyrev VV, Maleev VV, et al. The local manifestations of diphtheria [in Russian]. Zh Mikrobiol Epidemiol Immunobiol. 1994;4:19-22.

11.  Platonova TV, Korzhenkova MP. Clinical aspects of diphtheria in infants [in Russian]. Pediatriia. 1991;6:15-20.

12.  Pokrovskii VI, Ostrovskii NN, Astaf'eva NV, et al. Croup in toxic forms of diphtheria in adults [in Russian]. Ter Arkh. 1985;57:119-122.

13.  Russell K. Risk factors for predicting severe croup and bacterial tracheitis (master's thesis). 2006. Edmonton, AB: University of Alberta.

14.  Cherry J. Croup (laryngitis, laryngotracheitis, spasmodic croup, laryngotracheobronchitis, bacterial tracheitis, and laryngotracheobronchopneumonitis). In: Feigin R, ed. Textbook of pediatric infectious diseases, 5th ed. Philadelphia, PA: Elsevier, 2004:252-265.

15.  Davis G. An examination of the physiological consequences of chest wall distortion in infants with croup. Calgary: University of Calgary, 1985.

16.  Davis G, Cooper D, Mitchell I. The measurement of thoraco-abdominal asynchrony in infants with severe laryngotracheobronchitis. Chest. 1993;103:1842-1848.

17.  Crowe JE Jr. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine. 1995;13:415-421.

18.  Belshe RB, Newman FK, Anderson EL, et al. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis. 2004;190:2096-2103.

19.  Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015. http://www.topalbertadoctors.org (last accessed 22 October 2016).

20.  Sofer S, Duncan P, Chernick V. Bacterial tracheitis - an old disease rediscovered. Clin Pediatr (Phila). 1983;22:407-411.

21.  Jones R, Santos JI, Overall JC Jr. Bacterial tracheitis. JAMA. 1979;242:721-726.

22.  Donnelly BW, McMillan JA, Weiner LB. Bacterial tracheitis: report of eight new cases and review. Rev Infect Dis. 1990;12:729-735.

23.  Al-Mutairi B, Kirk V. Bacterial tracheitis in children: approach to diagnosis and treatment. Paediatr Child Health. 2004;9:25-30.

24.  Kasian GF, Bingham WT, Steinberg J, et al. Bacterial tracheitis in children. CMAJ. 1989;140:46-50.

25.  Bernstein T, Brilli R, Jacobs B. Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit. Clin Infect Dis. 1998;27:458-462.

26.  Wong VK, Mason WH. Branhamella catarrhalis as a cause of bacterial tracheitis. Pediatr Infect Dis J. 1987;6:945-946.

27.  Brook I. Aerobic and anaerobic microbiology of bacterial tracheitis in children. Pediatr Emerg Care. 1997;13:16-18.

28.  Midwinter K, Hodgson D, Yardley M. Paediatric epiglottitis: the influence of the Haemophilus influenzae b vaccine, a ten-year review in the Sheffield region. Clin Otolaryngol. 1999;24:447-448.

29.  Gonzalez Valdepena H, Wald E, Rose E, et al. Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience - a five-year review. Pediatrics. 1995;96:424-427.

30.  Gorelick M, Baker M. Epiglottitis in children, 1979 through 1992. Effects of Haemophilus influenzae type b immunization. Arch Pediatr Adolesc Med. 1994;148:47-50.

31.  Tunnessen W. Respiratory system: stridor - signs and symptoms in pediatrics. Philadelphia: JB Lippincott, 1983.

32.  Innes-Asher M. Infections of the upper respiratory tract. In: Taussig L, Landau L, eds. Pediatric respiratory medicine. St Louis: Mosby, 1999: 530-547.

33.  Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child. 1978;132:484-487.

34.  Chan AKJ, Langley JM, LeBlanc JC. Interobserver variability of croup scoring in clinical practice. Paediatr Child Health. 2001;6:347-351.

35.  Rizos JD, DiGravio BE, Sehl MJ, et al. The disposition of children with croup treated with racemic epinephrine and dexamethasone in the emergency department. J Emerg Med. 1998;16:535-539.

36.  Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998;339:498-503.

37.  Ledwith C, Shea L, Mauro R. Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med. 1995;25:331-337.

38.  Kunkel NC, Baker MD. Use of racemic epinephrine, dexamethasone, and mist in the outpatient management of croup. Pediatr Emerg Care. 1996;12:156-159.

39.  Prendergast M, Jones JS, Hartman D. Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med. 1994;12:613-616.

40.  Kelley PB, Simon JE. Racemic epinephrine use in croup and disposition. Am J Emerg Med. 1992;10:181-183.

41.  Corneli H, Bolte R. Outpatient use of racemic epinephrine in croup. Am Fam Physician. 1992;46:683-684.

42.  Kaditis AG, Wald ER. Viral croup: current diagnosis and treatment. Pediatr Infect Dis J. 1998;17:827-834.

43.  Klassen TP. Croup. A current perspective. Pediatr Clin North Am. 1999;46:1167-1178.

44.  Brown JC. The management of croup. Br Med Bull. 2002;61:189-202.

45.  Geelhoed GC. Croup. Pediatr Pulmonol. 1997;23:370-374.

46.  Sofer S, Dagan R, Tal A. The need for intubation in serious upper respiratory tract infection in pediatric patients (a retrospective study). Infection. 1991;19:131-134.

47.  Sendi K, Crysdale WS, Yoo J. Tracheitis: outcome of 1,700 cases presenting to the emergency department during two years. J Otolaryngol. 1992;21:20-24.

48.  Tan AK, Manoukian JJ. Hospitalized croup (bacterial and viral): the role of rigid endoscopy. J Otolaryngol. 1992:21;48-53.

49.  Dawson KP, Mogridge N, Downward G. Severe acute laryngotracheitis in Christchurch 1980-90. N Z Med J. 1991;104:374-375.

50.  Kairys SW, Marsh-Olmstead EM, O'Connor GT. Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics. 1989;83:683-693.

51.  Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet. 1992;340:745-748.

52.  Klassen TP, Feldman ME, Watters LK, et al. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med. 1994;331:285-289.

53.  Geelhoed GC, Macdonald WB. Oral and inhaled steroids in croup: a randomized, placebo-controlled trial. Pediatr Pulmonol. 1995;20:355-361.

54.  Geelhoed GC. Sixteen years of croup in a Western Australian teaching hospital: effects of routine steroid treatment. Ann Emerg Med. 1996;28:621-626.

55.  Bjornson CL, Klassen TP, Williamson J, et al. A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med. 2004;351:1306-1313.

56.  Russell KF, Liang Y, O'Gorman K, et al. Glucocorticoids for croup. Cochrane Database Syst Rev. 2011;(1):CD001955.

57.  Chub-Uppakarn S, Sangsupawanich P. A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. Int J Pediatr Otorhinolaryngol. 2007;71:473-477.

58.  Geelhoed GC, Macdonald WB. Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatr Pulmonol. 1995;20:362-368.

59.  Fifoot AA, Ting JY. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emerg Med Australas. 2007;19:51-58.

60.  Alshehri M, Almegamsi T, Hammdi A. Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research. 2005;16:65-72.

61.  Geelhoed GC. Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatr Emerg Care. 2005;21:359-362.

62.  Schimmer B, Parker K. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs - inhibitors of the synthesis and actions of adrenocortical hormones. In: Brunton L, Lazo J, Parker K, eds. Goodman and Gilman's the pharmacological basis of therapeutics. Columbus: McGraw-Hill, 2006:1587-612.

63.  Klassen TP, Craig WR, Moher D, et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA. 1998;279:1629-1632.

64.  Pedersen LV, Dahl M, Falk-Petersen HE, et al. Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudo-croup [in Danish]. Ugeskr Laeger. 1998;160:2253-2256.

65.  Cetinkaya F, Tufekci BS, Kutluk G. A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. Int J Pediatr Otorhinolaryngol. 2004;68:453-456.

66.  Dowell SF, Bresee JS. Severe varicella associated with steroid use. Pediatrics. 1993;92:223-228.

67.  Patel H, Macarthur C, Johnson D. Recent corticosteroid use and the risk of complicated varicella in otherwise immunocompetent children. Arch Pediatr Adolesc Med. 1996;150:409-414.

68.  Adair JC, Ring WH, Jordan WS, et al. Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis. Anesth Analg. 1971;50:649-655.

69.  Bjornson C, Russell K, Vandermeer B, et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2013;(10):CD006619.

70.  Kristjansson S, Berg-Kelly K, Winso E. Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr. 1994;83:1156-1160.

71.  Taussig LM, Castro O, Beaudry PH, et al. Treatment of laryngotracheobronchitis (croup). Use of intermittent positive-pressure breathing and racemic epinephrine. Am J Dis Child. 1975;129:790-793.

72.  Steele DW, Santucci KA, Wright RO, et al. Pulsus paradoxus: an objective measure of severity in croup. Am J Respir Crit Care Med. 1998;157:331-334.

73.  Fanconi S, Burger R, Maurer H, et al. Transcutaneous carbon dioxide pressure for monitoring patients with severe croup. J Pediatr. 1990;117:701-705.

74.  Corkey CW, Barker GA, Edmonds JF, et al. Radiographic tracheal diameter measurements in acute infectious croup: an objective scoring system. Crit Care Med. 1981;9:587-590.

75.  Gardner HG, Powell KR, Roden VJ, et al. The evaluation of racemic epinephrine in the treatment of infectious croup. Pediatrics. 1973;52:52-55.

76.  Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics. 1992;89:302-306.

77.  Janssens HM, Krijgsman A, Verbraak TF, et al. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. J Aerosol Med. 2004;17:51-61.

78.  Fink JB. Aerosol delivery to ventilated infant and pediatric patients. Respir Care. 2004;49:653-665.

79.  Schuepp KG, Straub D, Moller A, et al. Deposition of aerosols in infants and children. J Aerosol Med. 2004;17:153-156.

80.  Wildhaber JH, Monkhoff M, Sennhauser FH. Dosage regimens for inhaled therapy in children should be reconsidered. J Paediatr Child Health. 2002;38:115-116.

81.  Fogel JM, Berg IJ, Gerber MA, et al. Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing. J Pediatr. 1982;101:1028-1031.

82.  Weber JE, Chudnofsky CR, Younger JG, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics. 2001;107:E96.

83.  Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review. J Pediatr (Rio J). 2005;81:193-197.

84.  Butte MJ, Nguyen BX, Hutchison TJ, et al. Pediatric myocardial infarction after racemic epinephrine administration. Pediatrics. 1999;104:e9.

85.  Henry R. Moist air in the treatment of laryngotracheitis. Arch Dis Child. 1983;58:577.

86.  Lenney W, Milner AD. Treatment of acute viral croup. Arch Dis Child. 1978;53:704-706.

87.  Bourchier D, Dawson KP, Fergusson DM. Humidification in viral croup: a controlled trial. Aust Paediatr J. 1984;20:289-291.

88.  Skolnik N. Treatment of croup. A critical review. Am J Dis Child. 1989;143:1045-1049.

89.  Neto GM, Kentab O, Klassen TP, et al. A randomized controlled trial of mist in the acute treatment of moderate croup. Acad Emerg Med. 2002;9:873-879.

90.  Lavine E, Scolnik D. Lack of efficacy of humidification in the treatment of croup. Why do physicians persist in using an unproven modality? CJEM. 2001;3:209-212.

91.  Greally P, Cheng K, Tanner MS, et al. Children with croup presenting with scalds. BMJ. 1990;301:113.

92.  Terregino CA, Nairn SJ, Chansky ME, et al. The effect of Heliox on croup: a pilot study. Acad Emerg Med. 1998;5:1130-1133.

93.  Moraa I, Sturman N, McGuire T, et al. Heliox for croup in children. Cochrane Database Syst Rev. 2013;(12):CD006822.

94.  Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med. 2005;6:204-211.

95.  Kemper KJ, Ritz RH, Benson MS, et al. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med. 1991;19:356-359.

96.  Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J. 1979;26:206-212.

97.  Beckmann KR, Brueggemann WM Jr. Heliox treatment of severe croup. Am J Emerg Med. 2000;18:735-736.

98.  McGee DL, Wald DA, Hinchliffe S. Helium-oxygen therapy in the emergency department. J Emerg Med. 1997;15:291-296.

99.  DiCecco RJ, Rega PP. The application of heliox in the management of croup by an air ambulance service. Air Med J. 2004;23:33-35.

100.  Johnson D, Williamson J. Croup: duration of symptoms and impact on family functioning. Pediatr Res. 2001;49:83A.

101.  Johnson DW, Schuh S, Koren G, et al. Outpatient treatment of croup with nebulized dexamethasone. Arch Pediatr Adolesc Med. 1996;150:349-355.

使用此内容应接受我们的免责声明